DANIEL H GOLWYN
Medical Practice at Douglas Ave, Altamonte Springs, FL

License number
Florida 14438
Issued Date
Dec 31, 1973
Effective Date
Jul 27, 2012
Expiration Date
Jan 31, 2002
Category
Health Care
Type
Medical Doctor
Address
Address
375 Douglas Ave SUITE 2010, Altamonte Springs, FL 32714

Organization information

See more information about DANIEL H GOLWYN at bizstanding.com

Daniel H. Golwyn, M.D., PA

375 Douglas Ave, Altamonte Springs, FL 32714

Status:
Inactive
Registration:
Feb 14, 2000
State ID:
P00000015380
Business type:
Domestic for Profit Corporation
Director:
Douglas H. Golwyn Director, inactive
Agent:
Daniel H. Golwyn

Professional information

Daniel Golwyn Photo 1

Treatment Of Immunologically Based Disorders, Specifically Psoriasis

US Patent:
5147872, Sep 15, 1992
Filed:
Jun 19, 1990
Appl. No.:
7/540538
Inventors:
Daniel H. Golwyn - Altamonte Springs FL
International Classification:
A01N 4362, A61K 3155
US Classification:
514219
Abstract:
Methods and means for treating psoriasis, as well as Crohn's disease and other HLA-related disorders, to abate their symptoms, with a pharmaceutical diazepine having a component triazolo ring. HLA-related disorders amenable to such treatment include (i) persistent eruptive, granular, or ulcerative conditions of the skin, mouth, or gastrointestinal tract; and (ii) dibilitating inflammatory conditions of the circulatory, muscular, and nervous systems. This treatment alleviates abnormality or unbalance of patients' immune systems, such as an overabundance of natural killer cells and/or an abnormality of helper T-cell/suppressor T-cell ratio, and alleviates the self-cannibilism of the Koebner phenomenon, when present. Triazolobenzodiazepines, such as alprazolam or triazolam, and triazolothienodiazepines, such as etizolam, are examples of preferred treating compositions.


Daniel Golwyn Photo 2

Treatment Of Neurotransmitter-Linked Drug Abuse

US Patent:
4919916, Apr 24, 1990
Filed:
Nov 21, 1988
Appl. No.:
7/273777
Inventors:
Daniel H. Golwyn - Altamonte Springs FL
International Classification:
A61K 2700
US Classification:
424 10
Abstract:
Treatment of the abuse of those addictive drugs whose apparent mode of operation includes first an enhancement of neurotransmitter activity and subsequently a reduction in that activity--and in accompanying pleasurable sensations--to such an extent that abusers thereof feel compelled to repeat the experience. Examples of abused drugs for which treatment is suitable are amphetamines, cocaine, meperidine, phencyclidine, and new "designer" drugs. The treatment is by daily dosage of phenelzine or equivalent phenylalkylhydrazine so as to effect a degree of monoamine oxidase inhibition incompatible with the abused drug during the period of treatment and for at least a couple weeks thereafter. Concurrent usage is productive of a broad range of dangerous and frightening reactions, described in graphic detail to all patients undergoing such treatment, and any breach of the prohibition confirms the necessity of remaining free of the abused drug throughout. The treatment is effective in producing at least temporary and frequently longer-lasting abstinence.


Daniel Golwyn Photo 3

Treatment Of Immunologically Based Disorders, Specifically Crohn's Disease

US Patent:
5017575, May 21, 1991
Filed:
Jun 9, 1987
Appl. No.:
7/059889
Inventors:
Daniel H. Golwyn - Altamonte Springs FL
International Classification:
A61K 3455
US Classification:
514220
Abstract:
Means and methods for treating Crohn's disease, as an example of selectively influencing the immune systems of patients afflicted with intractable disorders and thereby abating or relieving the symptoms of such disorders, including many having an autoimmune abnormality or unbalance, such as an excessive concentration of killer T cells or an insufficient concentration of helper T cells or indeed both. A triazolo composition, such as a triazolobenzodiazepine, is administered to such a patient periodically in an amount effective to influence the immune system accordingly and to alleviate such symptoms, whereupon the dosage is gradually reduced to a maintenance level at which the symptoms do not recur but below which such recurrence is likely or certain.


Daniel Golwyn Photo 4

Treatment Of Neurotransmitter-Linked Drug Abuse

US Patent:
4786653, Nov 22, 1988
Filed:
Aug 24, 1987
Appl. No.:
7/088830
Inventors:
Daniel H. Golwyn - Altamonte Springs FL
International Classification:
A61K 31135
US Classification:
514654
Abstract:
Treatment of the abuse of those addictive drugs whose apparent mode of operation includes first an enhancement of neurotransmitter activity and subsequently a reduction in that activity--and in accompanying pleasurable sensations--to such an extent that abusers thereof feel compelled to repeat the experience. Examples of abused drugs for which treatment is suitable are amphetamines, cocaine, meperidine, phencyclidine, and new "designer" drugs. The treatment is by daily dosage of phenelzine or equivalent phenylalkylhydrazine so as to effect a degree of monoamine oxidase inhibition incompatible with the abused drug during the period of treatment and for at least a couple weeks thereafter. Concurrent usage is productive of a broad range of dangerous and frightening reactions, described in graphic detail to all patients undergoing such treatment, and any breach of the prohibition confirms the necessity of remaining free of the abused drug throughout. The treatment is effective in producing at least temporary and frequently longer-lasting abstinence.